1. Home
  2. Browse
  3. Drug Information

Drug Information

1201 - 1215 of 1915 Results
Sort Results:
Commentary: Omnaris (Ciclesonide) and Patanase (Olopatadine): New Nasal Sprays for Allergic Rhinitis June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008
Guideline: Perianal Crohn’s Disease (2003) June 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: Prevention of Migraine (US Headache Consortium) (2000) June 2008
Guideline: Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache (AAFP/ACP-ASIM) (2002) June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008
Guideline: Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease [Summary] (2006) June 2008
Article: Patanase (olopatadine) and Omnaris (ciclesonide) nasal sprays for allergic rhinitis June 2008
Commentary: Kidney Damage from Sodium Phosphate Bowel Preps May 2008
Other: Pharmacist Letter to Prescribers May 2008
Commentary: The New Auralgan Formulation May 2008
Guideline: Use of Hormonal Contraception in Women with Coexisting Medical Conditions May 2008
Commentary: Pristiq (Desvenlafaxine) May 2008
Chart: Authorized Generics Currently Available May 2008